In a reorganization first divulged in January, Philadelphia-based Spark Therapeutics, Roche’s gene therapy subsidiary, is letting go of 298 employees in Philadelphia. The cuts will come in three waves starting May 9 and ending Dec. 31, according to... — read more 

Gene therapy company Spark Therapeutics is laying off some employees. The company is the home of the first FDA-approved gene therapy Luxterna and is currently building its new Gene Therapy Innovation... — read more